Cytokines in Inflammatory Disease

This review aims to briefly discuss a short list of a broad variety of inflammatory cytokines. Numerous studies have implicated that inflammatory cytokines exert important effects with regard to various inflammatory diseases, yet the reports on their specific roles are not always consistent. They can be used as biomarkers to indicate or monitor disease or its progress, and also may serve as clinically applicable parameters for therapies. Yet, their precise role is not always clearly defined. Thus, in this review, we focus on the existing literature dealing with the biology of cytokines interleukin (IL)-6, IL-1, IL-33, tumor necrosis factor-alpha (TNF-α), IL-10, and IL-8. We will briefly focus on the correlations and role of these inflammatory mediators in the genesis of inflammatory impacts (e.g., shock, trauma, immune dysregulation, osteoporosis, and/or critical illness).

[1]  N. Gay,et al.  A leucine‐rich repeat peptide derived from the Drosophila Toll receptor forms extended filaments with a β‐sheet structure , 1991 .

[2]  C. Haasper,et al.  Prognostic value of procalcitonin (PCT) and/or interleukin-6 (IL-6) plasma levels after multiple trauma for the development of multi organ dysfunction syndrome (MODS) or sepsis. , 2010, Technology and health care : official journal of the European Society for Engineering and Medicine.

[3]  J Fernando Bazan,et al.  IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. , 2005, Immunity.

[4]  A. McKenzie,et al.  Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity , 2010, Nature.

[5]  Jian-ru Li,et al.  Minocycline Protects Against NLRP3 Inflammasome-Induced Inflammation and P53-Associated Apoptosis in Early Brain Injury After Subarachnoid Hemorrhage , 2016, Molecular Neurobiology.

[6]  P. Mercier,et al.  Endogenous IL-33 Is Highly Expressed in Mouse Epithelial Barrier Tissues, Lymphoid Organs, Brain, Embryos, and Inflamed Tissues: In Situ Analysis Using a Novel Il-33–LacZ Gene Trap Reporter Strain , 2012, The Journal of Immunology.

[7]  R. Ransohoff,et al.  The many roles of chemokines and chemokine receptors in inflammation. , 2006, The New England journal of medicine.

[8]  Simon A. Jones,et al.  Regulatory B cells are induced by gut microbiota–driven interleukin-1β and interleukin-6 production , 2014, Nature Medicine.

[9]  C. Janeway Approaching the asymptote? Evolution and revolution in immunology. , 1989, Cold Spring Harbor symposia on quantitative biology.

[10]  Changgui Shi,et al.  TNF-α suppresses osteogenic differentiation of MSCs by accelerating P2Y2 receptor in estrogen-deficiency induced osteoporosis. , 2018, Bone.

[11]  Kevin J. Tracey,et al.  Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia , 1987, Nature.

[12]  G. van Loo,et al.  Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis , 2014, Nature.

[13]  M. Jourdan,et al.  Constitutive production of interleukin-6 and immunologic features in cardiac myxomas. , 1990, Arthritis and rheumatism.

[14]  J. Zhen,et al.  AIM2 Mediates Inflammation-Associated Renal Damage in Hepatitis B Virus-Associated Glomerulonephritis by Regulating Caspase-1, IL-1β, and IL-18 , 2014, Mediators of inflammation.

[15]  J. Girard,et al.  IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy. , 2014, Current opinion in immunology.

[16]  J. Hošek,et al.  TNF-α signalling and inflammation: interactions between old acquaintances , 2013, Inflammation Research.

[17]  N. Rothwell,et al.  AIM2 and NLRC4 inflammasomes contribute with ASC to acute brain injury independently of NLRP3 , 2015, Proceedings of the National Academy of Sciences.

[18]  E. S. Baekkevold,et al.  Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. , 2003, The American journal of pathology.

[19]  F. Ciccia,et al.  Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)‐1β via the nucleotide‐binding domain and leucine‐rich repeat containing family pyrin 3(NLRP3)‐inflammasome activation: a possible implication for therapeutic decision in , 2015, Clinical and experimental immunology.

[20]  S. Akira,et al.  TLR signaling , 2006, Cell Death and Differentiation.

[21]  D. Solomon,et al.  Comparative Safety and Effectiveness of Denosumab Versus Zoledronic Acid in Patients With Osteoporosis: A Cohort Study , 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[22]  A. Martini,et al.  Pattern of interleukin-1beta secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations. , 2007, Arthritis and rheumatism.

[23]  N. Gay,et al.  A leucine-rich repeat peptide derived from the Drosophila Toll receptor forms extended filaments with a beta-sheet structure. , 1991, FEBS letters.

[24]  Yan Wang,et al.  Inhibition of P2X4 Suppresses Joint Inflammation and Damage in Collagen-Induced Arthritis , 2014, Inflammation.

[25]  L. Groebe,et al.  Monocytes/macrophages and/or neutrophils are the target of IL‐10 in the LPS endotoxemia model , 2010, European journal of immunology.

[26]  S. Smirnov,et al.  Cutting Edge: IL-26 Signals through a Novel Receptor Complex Composed of IL-20 Receptor 1 and IL-10 Receptor 2 1 , 2004, The Journal of Immunology.

[27]  W. Chu Tumor necrosis factor. , 2013, Cancer letters.

[28]  M. Gougerot-Pocidalo,et al.  Moderate inhibitory effect of interleukin-10 on human neutrophil and monocyte chemotaxis in vitro. , 1998, European cytokine network.

[29]  H. Griffiths,et al.  Gingipains from Porphyromonas gingivalis Increase the Chemotactic and Respiratory Burst-Priming Properties of the 77-Amino-Acid Interleukin-8 Variant , 2007, Infection and Immunity.

[30]  J. Tschopp,et al.  Inflammasome activators induce interleukin-1α secretion via distinct pathways with differential requirement for the protease function of caspase-1. , 2012, Immunity.

[31]  E. Remmers,et al.  De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. , 2002, Arthritis and rheumatism.

[32]  T. Mak,et al.  Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection , 1993, Cell.

[33]  B. Castner,et al.  A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. , 1997, Nature.

[34]  B. Mallard,et al.  Regulation of bovine intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) on cultured aortic endothelial cells. , 2001, Veterinary immunology and immunopathology.

[35]  C. Ryan,et al.  TNF-α/IL-10 Ratio Correlates with Burn Severity and May Serve as a Risk Predictor of Increased Susceptibility to Infections , 2016, Front. Public Health.

[36]  O. Dittrich‐Breiholz,et al.  Multiple control of interleukin‐8 gene expression , 2002, Journal of leukocyte biology.

[37]  M. Tada,et al.  Use of bisphosphonate might be important to improve bone mineral density in patients with rheumatoid arthritis even under tight control: the TOMORROW study , 2017, Rheumatology International.

[38]  M. Seishima,et al.  Lack of Interleukin-1&bgr; Decreases the Severity of Atherosclerosis in ApoE-Deficient Mice , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[39]  F. Budak,et al.  Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shock , 2006, European Journal of Clinical Microbiology and Infectious Diseases.

[40]  J. Lecron,et al.  Cytokine signatures in hereditary fever syndromes (HFS). , 2017, Cytokine & growth factor reviews.

[41]  Michelle L. Varney,et al.  IL-8 Directly Enhanced Endothelial Cell Survival, Proliferation, and Matrix Metalloproteinases Production and Regulated Angiogenesis1 , 2003, The Journal of Immunology.

[42]  M. Rincón,et al.  The two faces of IL-6 on Th1/Th2 differentiation. , 2002, Molecular immunology.

[43]  J. Inoue,et al.  MOLECULAR ANALYSIS OF CONSTITUTIVE IL-1α GENE EXPRESSION IN HUMAN MELANOMA CELLS: AUTHOCRINE STIMULATION THROUGH NF-κB ACTIVATION BY ENDOGENOUS IL-1α☆ , 1998 .

[44]  R. Zhou,et al.  DAMP-sensing receptors in sterile inflammation and inflammatory diseases , 2019, Nature Reviews Immunology.

[45]  H. Kita,et al.  IL-33-activated dendritic cells induce an atypical TH2-type response. , 2009, The Journal of allergy and clinical immunology.

[46]  F. Cantatore,et al.  Osteoporosis and rheumatic diseases. , 2014, Reumatismo.

[47]  K. Garcia,et al.  Hexameric Structure and Assembly of the Interleukin-6/IL-6 α-Receptor/gp130 Complex , 2003, Science.

[48]  J. Dagvadorj,et al.  The NLRP3 inflammasome is required for the development of hypoxemia in LPS/mechanical ventilation acute lung injury. , 2013, American journal of respiratory cell and molecular biology.

[49]  S. Wang,et al.  NLRP3 inflammasome activation contributes to the pathogenesis of rheumatoid arthritis , 2018, Clinical and experimental immunology.

[50]  C. Dinarello,et al.  DEMONSTRATION AND CHARACTERIZATION OF TWO DISTINCT HUMAN LEUKOCYTIC PYROGENS , 1974, The Journal of experimental medicine.

[51]  S. Cummings,et al.  Association of the G‐174C Variant in the Interleukin‐6 Promoter Region With Bone Loss and Fracture Risk in Older Women , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[52]  Polly Matzinger,et al.  Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses , 2004, Nature Reviews Immunology.

[53]  C. Quilici,et al.  Imbalanced gp130-Dependent Signaling in Macrophages Alters Macrophage Colony-Stimulating Factor Responsiveness via Regulation of c-fms Expression , 2004, Molecular and Cellular Biology.

[54]  R. Lockey,et al.  The role of the NLRP3 inflammasome in pulmonary diseases , 2015, Therapeutic advances in respiratory disease.

[55]  H. Broxmeyer,et al.  Increased osteoclast development after estrogen loss: mediation by interleukin-6 , 1992 .

[56]  Krzysztof Safranow,et al.  The association of IL-1beta, IL-2, and IL-6 gene polymorphisms with bone mineral density and osteoporosis in postmenopausal women. , 2010, European journal of obstetrics, gynecology, and reproductive biology.

[57]  H. Westerblad,et al.  TLR4 as receptor for HMGB1 induced muscle dysfunction in myositis , 2012, Annals of the rheumatic diseases.

[58]  N. Shao,et al.  Oxidized low-density lipoprotein induces secretion of interleukin-1β by macrophages via reactive oxygen species-dependent NLRP3 inflammasome activation. , 2012, Biochemical and biophysical research communications.

[59]  D. Herndon,et al.  Predictive Value of IL-8 for Sepsis and Severe Infections After Burn Injury: A Clinical Study , 2015, Shock.

[60]  Michael G. Katze,et al.  Into the Eye of the Cytokine Storm , 2012, Microbiology and Molecular Reviews.

[61]  Chengqi He,et al.  TNF-α and IL-6: the link between immune and bone system. , 2020, Current drug targets.

[62]  Xiaoling Hu,et al.  Expression of RANKL by peripheral neutrophils and its association with bone mineral density in COPD , 2017, Respirology.

[63]  T. Taniguchi,et al.  Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin , 1986, Nature.

[64]  R. Sacco,et al.  High-Sensitivity C-Reactive Protein and Interleukin-6–Dominant Inflammation and Ischemic Stroke Risk: The Northern Manhattan Study , 2014, Stroke.

[65]  R. Kimberly,et al.  Immunobiology of tumor necrosis factor receptor superfamily , 2002, Immunologic research.

[66]  Yan Jin,et al.  TNF‐α Inhibits FoxO1 by Upregulating miR‐705 to Aggravate Oxidative Damage in Bone Marrow‐Derived Mesenchymal Stem Cells during Osteoporosis , 2016, Stem cells.

[67]  Charles Natanson,et al.  Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis. , 2002, American journal of respiratory and critical care medicine.

[68]  G. Schett,et al.  What Are the Peripheral Blood Determinants for Increased Osteoclast Formation in the Various Inflammatory Diseases Associated With Bone Loss? , 2019, Front. Immunol..

[69]  S. Tural,et al.  Association between osteoporosis and polymorphisms of the IL-10 and TGF-beta genes in Turkish postmenopausal women. , 2013, Human immunology.

[70]  T. Nakashima,et al.  Tumor necrosis factor-α and interleukin-1β increase the Fas-mediated apoptosis of human osteoblasts , 1999 .

[71]  Sarah L. Doyle,et al.  An eye on the future of inflammasomes and drug development in AMD , 2013, Journal of Molecular Medicine.

[72]  K. Özoran,et al.  The Effects of Calcitriol Therapy on Serum Interleukin-1, Interleukin-6 and Tumour Necrosis Factor-α Concentrations in Post-menopausal Patients with Osteoporosis , 2004, The Journal of international medical research.

[73]  N. Žarković,et al.  Plasma interleukin-8 as a potential predictor of mortality in adult patients with severe traumatic brain injury. , 2007, The Tohoku journal of experimental medicine.

[74]  H. Chaves,et al.  Effects of Atorvastatin on Periodontitis of Rats Subjected to Glucocorticoid-Induced Osteoporosis. , 2016, Journal of periodontology.

[75]  N. Ikuta,et al.  Increased levels of interleukin-6, -8 and -10 are associated with fatal outcome following severe traumatic brain injury , 2014, Brain injury.

[76]  Ó. Coltell,et al.  [Prognostic value of interleukin 6 for death of patients with sepsis]. , 2016, Medicina clinica.

[77]  S. Rose-John Interleukin-6 Family Cytokines. , 2018, Cold Spring Harbor perspectives in biology.

[78]  M. Griensven Cytokines as biomarkers in polytraumatized patients , 2014 .

[79]  P. Tak,et al.  Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. , 2008, Pharmacology & therapeutics.

[80]  S. Maier,et al.  The danger-associated molecular pattern HMGB1 mediates the neuroinflammatory effects of methamphetamine , 2016, Brain, Behavior, and Immunity.

[81]  Yuzhang Wu,et al.  NLRP1 gene polymorphism influences gene transcription and is a risk factor for rheumatoid arthritis in han chinese. , 2012, Arthritis and rheumatism.

[82]  E. Alnemri,et al.  Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression1 , 2009, The Journal of Immunology.

[83]  Xiaopeng Wang,et al.  The selective NLRP3 inflammasome inhibitor MCC950 alleviates cholestatic liver injury and fibrosis in mice , 2019, International immunopharmacology.

[84]  Kang Zhang,et al.  Caspase-8 promotes NLRP1/NLRP3 inflammasome activation and IL-1β production in acute glaucoma , 2014, Proceedings of the National Academy of Sciences.

[85]  T. Allen,et al.  Interleukin 8 and acute lung injury. , 2014, Archives of pathology & laboratory medicine.

[86]  Wu Jiang,et al.  Targeting the NLRP3 inflammasome to attenuate spinal cord injury in mice , 2017, Journal of Neuroinflammation.

[87]  C. Fraser,et al.  Interleukin 10 knockout frail mice develop cardiac and vascular dysfunction with increased age , 2013, Experimental Gerontology.

[88]  Chang-Keun Lee,et al.  Effect of TNF inhibitors on bone mineral density in rheumatoid arthritis patients receiving bisphosphonate: a retrospective cohort study , 2019, Rheumatology International.

[89]  Li Xue,et al.  TNF-α contributes to postmenopausal osteoporosis by synergistically promoting RANKL-induced osteoclast formation. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[90]  R L Kassel,et al.  An endotoxin-induced serum factor that causes necrosis of tumors. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[91]  W. Mu,et al.  Silence of NLRP3 Suppresses Atherosclerosis and Stabilizes Plaques in Apolipoprotein E-Deficient Mice , 2014, Mediators of inflammation.

[92]  R. Ohls,et al.  Developmental changes in circulating IL-8/CXCL8 isoforms in neonates. , 2009, Cytokine.

[93]  Richard G. Ewers Into the Eye , 2011 .

[94]  H. Gerlach,et al.  Early detection of increased tumour necrosis factor alpha (TNFα) and soluble TNF receptor protein plasma levels after trauma reveals associations with the clinical course , 2001, Acta anaesthesiologica Scandinavica.

[95]  K. Asadullah,et al.  IL‐10 protects monocytes and macrophages from complement‐mediated lysis , 2009, Journal of leukocyte biology.

[96]  J. Lederer,et al.  Trauma equals danger—damage control by the immune system , 2012, Journal of leukocyte biology.

[97]  Tao Wang,et al.  [Detection and analysis of serum IL-10 and TGF-β1 in the SLE patients with osteoporosis or osteonecrosis]. , 2018, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology.

[98]  Francis J. Huber,et al.  Th17 cells express interleukin-10 receptor and are controlled by Foxp3⁻ and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner. , 2011, Immunity.

[99]  S. Tsunawaki,et al.  Expression of NADPH oxidases and enhanced H(2)O(2)-generating activity in human coronary artery endothelial cells upon induction with tumor necrosis factor-alpha. , 2008, International immunopharmacology.

[100]  M. Su,et al.  Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. , 1995, Science.

[101]  Y. Zhuo,et al.  HMGB1 promotes the activation of NLRP3 and caspase-8 inflammasomes via NF-κB pathway in acute glaucoma , 2015, Journal of Neuroinflammation.

[102]  M. Seibel,et al.  Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause. , 2001, The Journal of clinical endocrinology and metabolism.

[103]  G. Criner,et al.  Cigarette smoke silences innate lymphoid cell function and facilitates an exacerbated type I interleukin-33-dependent response to infection. , 2015, Immunity.

[104]  R. Sabat,et al.  Biology of interleukin-10. , 2010, Cytokine & growth factor reviews.

[105]  N. Warner,et al.  Function of Nod‐like receptors in microbial recognition and host defense , 2009, Immunological reviews.

[106]  Renu Gupta,et al.  Cytokine profiles in osteoporosis suggest a proresorptive bias , 2017, Menopause.

[107]  T. Bateman,et al.  An NLRP3 Mutation Causes Arthropathy and Osteoporosis in Humanized Mice. , 2016, Cell reports.

[108]  Donald W. Miller,et al.  Tumor Necrosis Factor-α Induces Cyclooxygenase-2 Expression and Prostaglandin Release in Brain Microvessel Endothelial Cells , 2001 .

[109]  T. Hirano,et al.  Molecular cloning and expression of an IL-6 signal transducer, gp130 , 1990, Cell.

[110]  A Wlodawer,et al.  Crystal structure of interleukin-10 reveals the functional dimer with an unexpected topological similarity to interferon gamma. , 1995, Structure.

[111]  C. Klein,et al.  Interleukin 10 receptor signaling: master regulator of intestinal mucosal homeostasis in mice and humans. , 2014, Advances in immunology.

[112]  D. Shayakhmetov,et al.  Interleukin 1α and the inflammatory process , 2016, Nature Immunology.

[113]  S. Nakae,et al.  The Alarmin Interleukin-33 Drives Protective Antiviral CD8+ T Cell Responses , 2012, Science.

[114]  Ran Wang,et al.  Association between interleukin-6 gene polymorphisms and bone mineral density: a meta-analysis. , 2013, Genetic testing and molecular biomarkers.

[115]  Matthew R. Jones,et al.  Roles of interleukin-6 in activation of STAT proteins and recruitment of neutrophils during Escherichia coli pneumonia. , 2006, The Journal of infectious diseases.

[116]  D. Rachmilewitz,et al.  Interleukin 10-deficient mice develop osteopenia, decreased bone formation, and mechanical fragility of long bones. , 2004, Gastroenterology.

[117]  M. Meisner,et al.  Markers for sepsis diagnosis: what is useful? , 2006, Critical care clinics.

[118]  J. Vincent,et al.  Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock , 1995, Journal of Clinical Immunology.

[119]  S. Fox,et al.  Interleukin-10 inhibits osteoclastogenesis by reducing NFATc1 expression and preventing its translocation to the nucleus , 2007, BMC Cell Biology.

[120]  Haichao Wang,et al.  Hydrogen peroxide stimulates macrophages and monocytes to actively release HMGB1 , 2007, Journal of leukocyte biology.

[121]  J. Reginster,et al.  Increase in cytokine production (IL-1 beta, IL-6, TNF-alpha but not IFN-gamma, GM-CSF or LIF) by stimulated whole blood cells in postmenopausal osteoporosis. , 1997, Maturitas.

[122]  C. Janeway,et al.  A human homologue of the Drosophila Toll protein signals activation of adaptive immunity , 1997, Nature.

[123]  T. Mosmann,et al.  Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones , 1989, The Journal of experimental medicine.

[124]  Daniel T. Fisher,et al.  Fever-range thermal stress promotes lymphocyte trafficking across high endothelial venules via an interleukin 6 trans-signaling mechanism , 2006, Nature Immunology.

[125]  Yang Zhang,et al.  Association of IL-6 G-174C polymorphism with bone mineral density , 2014, Journal of Bone and Mineral Metabolism.

[126]  K. Andrews,et al.  Interleukin 10 Antioxidant Effect Decreases Leukocytes/Endothelial Interaction Induced by Tumor Necrosis Factor &agr; , 2013, Shock.

[127]  H. Bramlett,et al.  Therapeutic Neutralization of the NLRP1 Inflammasome Reduces the Innate Immune Response and Improves Histopathology after Traumatic Brain Injury , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[128]  A. Zhang,et al.  Clinical relevance of single nucleotide polymorphisms within the entire NLRP3 gene in patients with major blunt trauma , 2011, Critical care.

[129]  B. Dalhus,et al.  Molecular Requirements for Sorting of the Chemokine Interleukin-8/CXCL8 to Endothelial Weibel-Palade Bodies* , 2009, The Journal of Biological Chemistry.

[130]  T. Bringman,et al.  Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors , 1986, Nature.

[131]  A. Fabre,et al.  Mutations in the autoinflammatory cryopyrin-associated periodic syndrome gene: epidemiological study and lessons from eight years of genetic analysis in France , 2010, Annals of the rheumatic diseases.

[132]  G. Wolf,et al.  Interleukin‐6 predicts recurrence and survival among head and neck cancer patients , 2008, Cancer.

[133]  T. Misteli,et al.  Release of chromatin protein HMGB1 by necrotic cells triggers inflammation , 2002, Nature.

[134]  Wen-Tung Wu,et al.  Association of interleukin-1 beta (-511C/T) polymorphisms with osteoporosis in postmenopausal women , 2010, Annals of Saudi medicine.

[135]  D. Lamarre,et al.  Interleukin‐10‐induced MARCH1 mediates intracellular sequestration of MHC class II in monocytes , 2008, European journal of immunology.

[136]  M. Lehner,et al.  Efficient Chemokine-dependent Migration and Primary and Secondary IL-12 Secretion by Human Dendritic Cells Stimulated Through Toll-like Receptors , 2007, Journal of immunotherapy.

[137]  B. Mroczko,et al.  Diagnostic usefulness of serum interleukin 6 (IL‐6) and C‐reactive protein (CRP) in the differentiation between pancreatic cancer and chronic pancreatitis , 2010, Journal of clinical laboratory analysis.

[138]  K. Asadullah,et al.  Expression profiling of IL‐10‐regulated genes in human monocytes and peripheral blood mononuclear cells from psoriatic patients during IL‐10 therapy , 2004, European journal of immunology.

[139]  J. Tschopp,et al.  Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome , 2011, Cell Death and Disease.

[140]  C. Dinarello,et al.  Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. , 2011, Blood.

[141]  U. Walker,et al.  Pharmacological treatment options for cryopyrin-associated periodic syndromes , 2017, Expert review of clinical pharmacology.

[142]  Raymond P Donnelly,et al.  Conformational Changes Mediate Interleukin-10 Receptor 2 (IL-10R2) Binding to IL-10 and Assembly of the Signaling Complex* , 2006, Journal of Biological Chemistry.

[143]  R. Locksley,et al.  Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation. , 2015, Immunity.

[144]  Recommendations for the management of autoinflammatory diseases , 2015, Annals of the rheumatic diseases.

[145]  Chengqi He,et al.  Pro-Inflammatory Cytokines: New Potential Therapeutic Targets for Obesity-Related Bone Disorders. , 2017, Current drug targets.

[146]  Wei Wu,et al.  Identification and functional characterization of a second chain of the interleukin‐10 receptor complex , 1997, The EMBO journal.

[147]  K. Winestock,et al.  IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes. , 1995, Journal of immunology.

[148]  Dirk E. Smith,et al.  The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33. , 2008, Cytokine.

[149]  A. Fischer,et al.  Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. , 2002, American journal of human genetics.

[150]  H. Lenz,et al.  Interleukin‐8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models , 2011, International journal of cancer.

[151]  U. Maggiore,et al.  Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[152]  L. O’Neill,et al.  TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. , 2006, Trends in immunology.

[153]  S. Brianza,et al.  Estrogen deficiency increases osteoclastogenesis up-regulating T cells activity: a key mechanism in osteoporosis. , 2008, Bone.

[154]  C. Ding,et al.  Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study. , 2008, The Journal of clinical endocrinology and metabolism.

[155]  K. Steinberg,et al.  Anti-interleukin 8 autoantibody: interleukin 8 complexes in the acute respiratory distress syndrome. Relationship between the complexes and clinical disease activity. , 2001, American journal of respiratory and critical care medicine.

[156]  W. Fraser,et al.  Response of serum interleukin-6 in patients undergoing elective surgery of varying severity. , 1990, Clinical science.

[157]  J. Collins,et al.  Structural conservation of interferon gamma among vertebrates. , 2009, Cytokine & growth factor reviews.

[158]  J. Fajar,et al.  The association between interleukin 6 −174 G/C gene polymorphism and the risk of osteoporosis: A meta-analysis , 2016, Journal of Taibah University Medical Sciences.

[159]  L. Crepaldi,et al.  Upregulation of IL-10R1 expression is required to render human neutrophils fully responsive to IL-10 , 2001 .

[160]  S. Yakout,et al.  Inflammation as a contributing factor among postmenopausal Saudi women with osteoporosis , 2017, Medicine.

[161]  L. Ginaldi,et al.  Interleukin-33 serum levels in postmenopausal women with osteoporosis , 2019, Scientific Reports.

[162]  S. Yakout,et al.  Inflammatory and bone turnover markers in relation to PTH and vitamin D status among saudi postmenopausal women with and without osteoporosis. , 2014, International journal of clinical and experimental medicine.

[163]  K. Kang,et al.  Human umbilical cord blood-stem cells direct macrophage polarization and block inflammasome activation to alleviate rheumatoid arthritis , 2016, Cell Death & Disease.

[164]  Joseph C. Sun,et al.  Cutting Edge: IL-15-Independent NK Cell Response to Mouse Cytomegalovirus Infection1 , 2009, The Journal of Immunology.

[165]  T. van der Poll,et al.  Ventilator-induced Lung Injury Is Mediated by the NLRP3 Inflammasome , 2012, Anesthesiology.

[166]  G. Häcker,et al.  Activation of the immune system by bacterial CpG‐DNA , 2002, Immunology.

[167]  K. Rajewsky,et al.  Interleukin-10-deficient mice develop chronic enterocolitis , 1993, Cell.

[168]  T. S. Wilkinson,et al.  Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. , 2001, Immunity.

[169]  M. Gaestel,et al.  Cross-regulation of cytokine signalling: pro-inflammatory cytokines restrict IL-6 signalling through receptor internalisation and degradation , 2010, Journal of Cell Science.

[170]  Yuehua Wu,et al.  Efficacy and Safety of Denosumab in Postmenopausal Women With Osteoporosis , 2015, Medicine.

[171]  M. Baggiolini,et al.  Interleukin‐8, a chemotactic and inflammatory cytokine , 1992, FEBS letters.

[172]  F. Martinon,et al.  The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. , 2002, Molecular cell.

[173]  F. Schaper,et al.  Interleukin-6: Biology, signaling and strategies of blockade. , 2015, Cytokine & growth factor reviews.

[174]  J. Dipiro,et al.  Interleukin-10 is associated with the development of sepsis in trauma patients. , 1996, The Journal of trauma.

[175]  P. Heinrich,et al.  Principles of interleukin (IL)-6-type cytokine signalling and its regulation. , 2003, The Biochemical journal.

[176]  Lijun Xu,et al.  Melatonin Suppresses Estrogen Deficiency-Induced Osteoporosis and Promotes Osteoblastogenesis by Inactivating the NLRP3 Inflammasome , 2018, Calcified Tissue International.

[177]  A. Lewin,et al.  The NLRP3 Inflammasome and its Role in Age-Related Macular Degeneration. , 2016, Advances in experimental medicine and biology.

[178]  T. Nakashima,et al.  Tumor necrosis factor-alpha and interleukin-1beta increase the Fas-mediated apoptosis of human osteoblasts. , 1999, The Journal of laboratory and clinical medicine.

[179]  Fei Li,et al.  Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury , 2018, Neurobiology of Disease.

[180]  S. Gupta,et al.  IL-18BP is decreased in osteoporotic women: Prevents Inflammasome mediated IL-18 activation and reduces Th17 differentiation , 2016, Scientific Reports.

[181]  W. Lems,et al.  CXCL8 and CCL20 Enhance Osteoclastogenesis via Modulation of Cytokine Production by Human Primary Osteoblasts , 2015, PloS one.

[182]  I. McInnes,et al.  IL‐33 is a chemoattractant for human Th2 cells , 2007, European journal of immunology.

[183]  R. Kyle,et al.  Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor. , 1992, Cytokine.

[184]  M. Grell Tumor necrosis factor (TNF) receptors in cellular signaling of soluble and membrane-expressed TNF. , 1995, Journal of inflammation.

[185]  Y. Carmi,et al.  The Role of Macrophage-Derived IL-1 in Induction and Maintenance of Angiogenesis1 , 2009, The Journal of Immunology.

[186]  Masatoshi Suzuki,et al.  Production of Mice Deficient in Genes for Interleukin (IL)-1α, IL-1β, IL-1α/β, and IL-1 Receptor Antagonist Shows that IL-1β Is Crucial in Turpentine-induced Fever Development and Glucocorticoid Secretion , 1998, The Journal of experimental medicine.

[187]  M. Willcox,et al.  Inflammasomes, the eye and anti-inflammasome therapy , 2017, Eye.

[188]  M. Karin,et al.  IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. , 2009, Cancer cell.

[189]  M. Netea,et al.  Bone marrow‐specific caspase‐1/11 deficiency inhibits atherosclerosis development in Ldlr−/− mice , 2015, The FEBS journal.

[190]  W. D. Dietrich,et al.  Inflammasome proteins as biomarkers of traumatic brain injury , 2018, PLoS ONE.

[191]  B. Relja,et al.  Nlrp1 inflammasome is downregulated in trauma patients , 2015, Journal of Molecular Medicine.

[192]  Y. Liu,et al.  Up-Regulation of IL-10R1 Expression Is Required to Render Human Neutrophils Fully Responsive to IL-101 , 2001, The Journal of Immunology.

[193]  T. Lawrence The nuclear factor NF-kappaB pathway in inflammation. , 2009, Cold Spring Harbor perspectives in biology.

[194]  M. V. von Herrath,et al.  Alpha cells, the main source of IL-1β in human pancreas. , 2017, Journal of autoimmunity.

[195]  V. Pascual,et al.  From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines , 2012, Nature Immunology.

[196]  D. Weiner,et al.  Interleukin 33: a switch-hitting cytokine. , 2014, Current opinion in immunology.

[197]  B. Beutler,et al.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. , 1985, Science.

[198]  J. Bradley,et al.  TNF‐mediated inflammatory disease , 2008, The Journal of pathology.

[199]  K. Moore,et al.  NLRP3 inflamasomes are required for atherogenesis and activated by cholesterol crystals that form early in disease , 2010, Nature.

[200]  F. Martinon,et al.  NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. , 2004, Immunity.

[201]  P. Matzinger Tolerance, danger, and the extended family. , 1994, Annual review of immunology.

[202]  L. Joosten,et al.  Inflammatory arthritis in caspase 1 gene-deficient mice: contribution of proteinase 3 to caspase 1-independent production of bioactive interleukin-1beta. , 2009, Arthritis and rheumatism.

[203]  R. Gambari,et al.  Mapping the Transcriptional Machinery of the IL-8 Gene in Human Bronchial Epithelial Cells , 2011, The Journal of Immunology.

[204]  N. Parameswaran,et al.  Loss of interleukin‐10 exacerbates early Type‐1 diabetes‐induced bone loss , 2020, Journal of cellular physiology.

[205]  P. Libby,et al.  The Present and FutureReview Topic of the WeekInterleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond , 2017 .

[206]  Q. Zuo,et al.  Ginsenoside Rb1 prevents interleukin-1 beta induced inflammation and apoptosis in human articular chondrocytes , 2013, International Orthopaedics.

[207]  C. Dinarello,et al.  Non-redundant properties of IL-1α and IL-1β during acute colon inflammation in mice , 2013, Gut.

[208]  K. Dingle,et al.  Multivariate Comparison of Cytokine Profiles for Normal- and Low-Bone-Density Subjects , 2019, Diagnostics.

[209]  L. Yan,et al.  Meta-analysis of association between IL-6 -634C/G polymorphism and osteoporosis. , 2015, Genetics and molecular research : GMR.

[210]  Werner Müller,et al.  Interleukin‐10 derived from macrophages and/or neutrophils regulates the inflammatory response to LPS but not the response to CpG DNA , 2006, European journal of immunology.

[211]  Peter A. Ward,et al.  Harmful molecular mechanisms in sepsis , 2008, Nature Reviews Immunology.

[212]  R. Flavell,et al.  The light and the dark sides of Interleukin-10 in immune-mediated diseases and cancer. , 2016, Cytokine & growth factor reviews.

[213]  R. Thompson,et al.  Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats. , 1994, The Journal of clinical investigation.

[214]  Jiwang Zhang,et al.  TNF-α/Fas-RIP-1-induced cell death signaling separates murine hematopoietic stem cells/progenitors into 2 distinct populations. , 2011, Blood.

[215]  J. Lederer,et al.  A Protective Role for Inflammasome Activation Following Injury , 2012, Shock.

[216]  R. Kolodner,et al.  Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle–Wells syndrome , 2001, Nature Genetics.

[217]  A. Mantovani,et al.  Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. , 1993, Science.

[218]  P. Gourdy,et al.  The pro‐Th2 cytokine IL‐33 directly interacts with invariant NKT and NK cells to induce IFN‐γ production , 2009, European journal of immunology.

[219]  Ke Chen,et al.  NLRP3 inflammasome activation in mesenchymal stem cells inhibits osteogenic differentiation and enhances adipogenic differentiation. , 2017, Biochemical and biophysical research communications.

[220]  Tack-Joong Kim,et al.  Triglyceride-induced macrophage cell death is triggered by caspase-1. , 2013, Biological & pharmaceutical bulletin.

[221]  S. Akira,et al.  Pattern Recognition Receptors and Inflammation , 2010, Cell.

[222]  L. Joosten,et al.  Inflammasome-independent Role of Apoptosis-associated Speck-like Protein Containing a CARD (ASC) in T Cell Priming Is Critical for Collagen-induced Arthritis* , 2010, The Journal of Biological Chemistry.

[223]  J. Scheller,et al.  Inflammation-Induced IL-6 Functions as a Natural Brake on Macrophages and Limits GN. , 2015, Journal of the American Society of Nephrology : JASN.

[224]  R. Ramjeesingh,et al.  Interleukin‐8 secreted by endothelial cells induces Chemotaxis of melanoma cells through the chemokine receptor CXCR1 , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[225]  L. Moldawer,et al.  Is there value in plasma cytokine measurements in patients with severe trauma and sepsis? , 2013, Methods.

[226]  Nicole Nelson,et al.  A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells , 1997, Nature.

[227]  M. Gubina,et al.  Diagnostic accuracy of procalcitonin and interleukin-6 values for predicting bacteremia and clinical sepsis in febrile neutropenic children with cancer , 2006, European Journal of Clinical Microbiology and Infectious Diseases.

[228]  Yoshiro Kobayashi The role of chemokines in neutrophil biology. , 2008, Frontiers in bioscience : a journal and virtual library.

[229]  L. Joosten,et al.  Inflammasome-independent regulation of IL-1-family cytokines. , 2015, Annual review of immunology.

[230]  C. Fielding,et al.  IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[231]  S. Rose-John,et al.  Pore-forming toxins trigger shedding of receptors for interleukin 6 and lipopolysaccharide. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[232]  B. Koller,et al.  NLRP1-Dependent Pyroptosis Leads to Acute Lung Injury and Morbidity in Mice , 2012, The Journal of Immunology.

[233]  E. Hoppenreijs,et al.  A new autoinflammatory and autoimmune syndrome associated with NLRP1 mutations: NAIAD (NLRP1-associated autoinflammation with arthritis and dyskeratosis) , 2016, Annals of the rheumatic diseases.

[234]  P. V. van Eeden,et al.  Sustained Elevation of Resistin, NGAL and IL-8 Are Associated with Severe Sepsis/Septic Shock in the Emergency Department , 2014, PloS one.

[235]  C. Dinarello,et al.  Treating inflammation by blocking interleukin-1 in humans. , 2013, Seminars in immunology.

[236]  J. Hollyfield,et al.  NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components , 2012, Nature Medicine.

[237]  K. Nas,et al.  Possible pathogenetic role of new cytokines in postmenopausal osteoporosis and changes during calcitonin plus calcium therapy , 2002, Rheumatology International.

[238]  J. Cañete,et al.  The safety of tumor necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis , 2016, Expert opinion on drug safety.

[239]  C. Hunter,et al.  IL-6 as a keystone cytokine in health and disease , 2015, Nature Immunology.

[240]  D. Boumpas,et al.  Enhanced activity of NLRP3 inflammasome in peripheral blood cells of patients with active rheumatoid arthritis , 2015, Arthritis Research & Therapy.

[241]  C. Shao,et al.  Inflammatory Cytokine-Induced Intercellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule-1 in Mesenchymal Stem Cells Are Critical for Immunosuppression , 2010, The Journal of Immunology.

[242]  S. Tsao,et al.  Enhanced IL-6/IL-6R Signaling Promotes Growth and Malignant Properties in EBV-Infected Premalignant and Cancerous Nasopharyngeal Epithelial Cells , 2013, PloS one.

[243]  A. Aygun,et al.  Serum IL-1β, IL-6, IL-8, and TNF-α Levels in Early Diagnosis and Management of Neonatal Sepsis , 2008, Mediators of inflammation.

[244]  H. Olivecrona,et al.  Long-term safety profile of anakinra in patients with severe cryopyrin-associated periodic syndromes , 2016, Rheumatology.

[245]  J. Inoue,et al.  Molecular analysis of constitutive IL-1alpha gene expression in human melanoma cells: autocrine stimulation through NF-kappaB activation by endogenous IL-1alpha. , 1998, Cytokine.

[246]  Yangang Wang,et al.  Resveratrol pretreatment attenuates traumatic brain injury in rats by suppressing NLRP3 inflammasome activation via SIRT1. , 2017, Molecular medicine reports.

[247]  Delphine A. Lacorre,et al.  IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo , 2007, Proceedings of the National Academy of Sciences.

[248]  N. Hempel,et al.  Redox-control of the alarmin, Interleukin-1α☆ , 2013, Redox biology.

[249]  K. Kang,et al.  Auranofin Inhibits RANKL-Induced Osteoclastogenesis by Suppressing Inhibitors of κB Kinase and Inflammasome-Mediated Interleukin-1β Secretion , 2019, Oxidative medicine and cellular longevity.

[250]  J. P. de Rivero Vaccari,et al.  Traumatic Brain Injury-Induced Acute Lung Injury: Evidence for Activation and Inhibition of a Neural-Respiratory-Inflammasome Axis. , 2018, Journal of neurotrauma.

[251]  T. Ma,et al.  IL-1β Causes an Increase in Intestinal Epithelial Tight Junction Permeability1 , 2007, The Journal of Immunology.

[252]  C. Dinarello,et al.  The Interleukin-1α Precursor is Biologically Active and is Likely a Key Alarmin in the IL-1 Family of Cytokines , 2013, Front. Immunol..

[253]  A. Yoshimura,et al.  IL-6 trans-signaling promotes pancreatitis-associated lung injury and lethality. , 2013, The Journal of clinical investigation.

[254]  P. Lacativa,et al.  Osteoporosis and inflammation. , 2010, Arquivos brasileiros de endocrinologia e metabologia.

[255]  U. Steckholzer,et al.  Relationship of interleukin-10 plasma levels to severity of injury and clinical outcome in injured patients. , 1997, The Journal of trauma.

[256]  F. Horn,et al.  Analysis of Stat3 (signal transducer and activator of transcription 3) dimerization by fluorescence resonance energy transfer in living cells. , 2004, The Biochemical journal.

[257]  M. Saraya,et al.  Evaluation of leptin, interleukin-1 beta and tumor necrosis factor alpha in serum of malaria patients as prognostic markers of treatment outcome. , 2014, Asian Pacific journal of tropical biomedicine.

[258]  R. Pierce,et al.  Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease. , 2013, The Journal of clinical investigation.

[259]  J. Piette,et al.  Interleukin-6 receptor shedding is enhanced by interleukin-1beta and tumor necrosis factor alpha and is partially mediated by tumor necrosis factor alpha-converting enzyme in osteoblast-like cells. , 2005, Arthritis and rheumatism.

[260]  G. Dubyak,et al.  Nonclassical IL-1β Secretion Stimulated by P2X7 Receptors Is Dependent on Inflammasome Activation and Correlated with Exosome Release in Murine Macrophages1 , 2007, The Journal of Immunology.

[261]  A. De La Hera,et al.  Mortality in Patients With Septic Shock Correlates With Anti-Inflammatory But not Proinflammatory Immunomodulatory Molecules , 2011, Journal of intensive care medicine.

[262]  Min Wu,et al.  11β-Hydroxysteroid dehydrogenase 1 inhibition attenuates collagen-induced arthritis. , 2013, International Immunopharmacology.

[263]  O. Reikerås,et al.  Activation of Markers of Inflammation, Coagulation and Fibrinolysis in Musculoskeletal Trauma , 2014, PloS one.

[264]  G. Fernández,et al.  Interleukin-10 controls human peripheral PMN activation triggered by lipopolysaccharide. , 2013, Cytokine.

[265]  C. Dinarello,et al.  Immunological and inflammatory functions of the interleukin-1 family. , 2009, Annual review of immunology.

[266]  D. Miller,et al.  Tumor necrosis factor-alpha induces cyclooxygenase-2 expression and prostaglandin release in brain microvessel endothelial cells. , 2001, The Journal of pharmacology and experimental therapeutics.

[267]  K. Safranow,et al.  TNF-α and IL10 gene polymorphisms in women with postmenopausal osteoporosis. , 2016, European journal of obstetrics, gynecology, and reproductive biology.

[268]  T. van der Poll,et al.  Severe sepsis and septic shock. , 2013, The New England journal of medicine.

[269]  Richard T. Lee,et al.  Interleukin 33 as a Mechanically Responsive Cytokine Secreted by Living Cells* , 2012, The Journal of Biological Chemistry.